New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
08:38 EDTCBRXColumbia Laboratories sells IP and technology for Legatrin for $2.2M
Columbia Laboratories announced that Lil' Drug Store Products exercised its option to purchase the Intellectual Property Rights and Technology related to Legatrin P.M. Columbia licensed this product to Lil' Drug Store Products approximately fourteen years ago and has received annual royalties. Columbia will receive approximately $2.2M for the sale.
News For CBRX From The Last 14 Days
Check below for free stories on CBRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CBRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use